<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="86249">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01982357</url>
  </required_header>
  <id_info>
    <org_study_id>NIH/LAMMP-2013-9505</org_study_id>
    <nct_id>NCT01982357</nct_id>
  </id_info>
  <brief_title>Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies</brief_title>
  <official_title>Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beckman Laser Institute University of California Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alterations to microvascular blood flow in premature infants, are known to contribute to
      several major disease entities.

      The optically-measured tissue blood flow, to determine tissue perfusion that can be use to
      detect blood loss.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The researchers want to use optical technologies to non-invasively detect blood flow that
      can tell the onset of blood loss. The research can measure blood flow in stable premature
      infants in the Neonatal Intensive Care Unit over the duration of several weeks.

      The technologies are Laser Speckle Imaging and Diffuse Optical Spectroscopy.

      Laser Speckle Imaging non-contact imaging technology, is sensitive to blood flow in
      superficial tissues. Diffuse Optical Spectroscopy, a probe-based contact technology like
      pulse oximetry, measures hemoglobin concentrations and states deeper below the skin surface.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Normal Blood flow in premature infant</measure>
    <time_frame>up to 4 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Infant, Premature, Diseases</condition>
  <arm_group>
    <arm_group_label>premature infant</arm_group_label>
    <description>Laser Speckle Imaging and Diffuse Optical Spectroscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser Speckle Imaging and Diffuse Optical Spectroscopy</intervention_name>
    <description>Laser Speckle Imaging and Diffuse Optical Spectroscopy</description>
    <arm_group_label>premature infant</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will be selected from University of California Irvine Medical Center at
        Neonate Intensive Care Unit
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  premature infants born or transferred to neonatal intensive care unit with a
             gestational age of 28-35 weeks

        Exclusion Criteria:

          -  NONE premature infants born or transferred to neonatal intensive care unit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Month</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omid Fathi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute, UCI</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernard Choi, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Beckman Laser Institute, UCI</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Omid Fathi, MD</last_name>
    <phone>714.456.5285</phone>
    <email>ofathi@uci.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCIMC</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omid Fathi, MD</last_name>
      <phone>714-456-5285</phone>
      <email>ofathi@uci.edu</email>
    </contact>
    <investigator>
      <last_name>Jack Sill, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cherry UY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fayez Bany-Mohammed, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Courtney Merchant, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mariam Abdul-Latif, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 8, 2017</lastchanged_date>
  <firstreceived_date>November 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Beckman Laser Institute and Medical Center</investigator_full_name>
    <investigator_title>Omid Fathi, M.D., Pediatrics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infant, Premature, Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
